Droxinavir

Overview

Droxinavir (SC-55389A free base) is an HIV-1 protease inhibitor. Droxinavir binds to the S2 and S2' subsites of HIV-1 protease, and this interaction is regulated by protease amino acid residue 88, where the N88S mutation confers viral resistance. Droxinavir can be used in studies related to human immunodeficiency virus type 1 infection .

Application

Products | Products > Disease Areas > HIV-1 Infection | Products > Disease Areas > Infection | Products > Disease Areas > Urogenital Disease | Products > Disease Areas > HIV Infection | Products > Disease Areas > Sexually Transmitted Disease | Products > Signaling Pathways > Anti-infection | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Infection | Products > Signaling Pathways > HIV | Products > Signaling Pathways > HIV Protease

Product Information

• Catalog No.: HY-125494A
• CAS No.: 159910-86-8
• Molecular Formula: C29H51N5O4
• Molecular Weight: 533.75
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source